TherapeuticsMD (NYSEMKT:TXMD) has received a short term rating of hold from experts at Zacks with a rank of 3. The stock has been rated an average of 1 by 4 Brokerage Firm. 4 Wall Street Firms have rated the stock as a strong buys.
Other Equity analysts have also commented on the company shares. Goldman Sachs initiates coverage on TherapeuticsMD (NYSEMKT:TXMD) . The global brokerage major announces a current price target of $10 per share. Analysts at the Goldman Sachs have a current rating of Buy on the shares. The rating by the firm was issued on April 4, 2016.
TherapeuticsMD (NYSEMKT:TXMD): According to 4 Analysts, The short term target price has been estimated at $ 15.63.The target price could deviate by a maximum of $2.5 from the forecast price. In the near term, the target price could hit a high of $18 and a low of $ 13.
TherapeuticsMD (NYSEMKT:TXMD) witnessed a decline in the market cap on Tuesday as its shares dropped 1.15% or 0.1 points. After the session commenced at $8.75, the stock reached the higher end at $8.75 while it hit a low of $8.39. With the volume soaring to 1,034,633 shares, the last trade was called at $8.62. The company has a 52-week high of $11.26. The company has a market cap of $1,692 million and there are 196,263,700 shares in outstanding. The 52-week low of the share price is $5.18.
Shares of TherapeuticsMD, Inc. rose by 0.94% in the last five trading days and 5.51% for the last 4 weeks. TherapeuticsMD, Inc. is up 34.27% in the last 3-month period. Year-to-Date the stock performance stands at -16.88%.
TherapeuticsMD, Inc. is a womens health care product company. The Company is engaged in creating and commercializing products for women. The Company is focused on conducting clinical trials necessary for regulatory approval and commercialization of advanced hormone therapy pharmaceutical products. It manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter (OTC) vitamins. It markets its prescription and OTC prenatal vitamins and other products under its vitaMedMD brand name and duplicate formulations of its prescription prenatal vitamin products, also referred to as generic formulations, under its BocaGreenMD brand name. The Companys products include prenatal vitamins, vitaMedMD Plus Rx, vitaMedMD One Rx, vitaMedMD RediChew Rx and BocaGreenMD Prena1 line of prescription prenatal vitamins, which included three prescription prenatal vitamins that were generic formulations of its vitaMedMD-branded prescription prenatal vitamins.